The question that surfaces in every founder's inbox
A seed investor asks for your IP strategy on a Tuesday call, and you realize you have never had to answer it out loud. Maybe you filed a provisional application six months ago and forgot about it. Maybe you have not filed anything because you were busy building. Maybe you demoed the product at a conference before anyone mentioned patents at all. None of these situations are fatal, but each one changes what you can still do, and how you should talk about it in the room.
This is not about whether your idea qualifies for a patent. That is a question for a patent attorney, and it depends on facts specific to your invention. What follows is a way to think about sequencing: what to consider before you file, before you disclose, and before you raise, so the decisions you make now do not close doors later.
Why investors ask about IP at all
Investors rarely care about patents as legal instruments. They care about what patents signal.
A thoughtful IP posture tells an investor three things. First, that you understand your competitive landscape well enough to know what makes your approach different, not just faster or cheaper. Second, that you have thought about what happens when a well-funded competitor notices you are working. Third, that you treat the company's assets, including ideas, as something worth protecting deliberately rather than accidentally.
None of this requires an issued patent at the seed stage. Most investors know that patent prosecution, the process of negotiating with a patent office over what you can claim, takes years. What they are evaluating is whether you have a plan, not a certificate. A pending application with a clear provisional filing date can carry real weight in diligence, especially in hardware, biotech, or any category where the underlying mechanism is the product.
The practical framework here is to separate two questions in your own head: "do I have something protectable" and "have I acted like someone who takes protection seriously." Investors are mostly evaluating the second, even when they think they are asking the first.
What a moat actually needs to hold
A patent moat is not one filing. It is a portfolio logic: a reason that a competitor with more money than you still cannot simply copy the thing that matters. When you talk to investors, it helps to be able to describe your moat in a sentence that does not depend on the word "patent" alone. Something like: the mechanism is hard to reverse-engineer, the manufacturing process is non-obvious, and we have a provisional application on the core method with more filings planned as the product matures.
That sentence works because it shows layering. A single patent application, even a strong one, is a start, not a moat.
Timing: what happens before you file, and what happens after
The single most consequential timing decision in early-stage IP strategy is the relationship between public disclosure and filing. In the United States, an inventor has a limited grace period after their own public disclosure to file a patent application, but many other countries offer no such grace period at all. Once you disclose publicly and file late, you may lose the ability to seek patent protection in those countries entirely, regardless of how strong the invention is.
"Public disclosure" is a broader category than most first-time founders assume. It can include:
- A product demo at a conference or pitch competition
- A detailed blog post or press release describing how the invention works
- A crowdfunding campaign page with technical specifics
- A conversation with a potential investor or manufacturer without a nondisclosure agreement in place
This is the kind of question a patent attorney would ask early: what have you already said publicly, to whom, and when. If you have already disclosed something, that does not necessarily end the conversation, but it changes the analysis and the urgency.
The general sequencing principle worth internalizing: figure out what is protectable before you talk about it widely, not after. That does not mean going silent for a year. It means treating a provisional filing, an affordable and relatively fast filing that establishes a priority date without requiring a full formal application, as a first step before your first public demo or pitch, if protection is a genuine goal for the invention. From that priority date, you typically have twelve months to file a full nonprovisional application, which gives you a window to keep building and fundraising while a placeholder date is already secured.
Fundraising as a disclosure event
Founders often think of fundraising conversations as private by default. They are not automatically private. A pitch deck emailed to forty angel investors, most of whom you have never met and none of whom signed anything, functions as a public disclosure in some legal contexts. This is one factor that tends to matter when founders later try to understand why a filing window closed faster than they expected.
A reasonable practice is to keep the technical core of an invention, the part you might eventually claim in a patent, out of materials that circulate without any confidentiality expectation, until a provisional application is on file. After that filing, the priority date is secured, and you generally have more freedom to discuss the invention in detail during fundraising without jeopardizing the same rights.
Patents versus trade secrets: a decision, not a default
A patent and a trade secret solve different problems, and founders sometimes assume patenting is simply the more serious or more advanced choice. It is not automatically either. It is a tradeoff.
A patent gives you a time-limited, government-granted right to exclude others from making, using, or selling the claimed invention, in exchange for publicly disclosing how it works. A trade secret protects information indefinitely, as long as you keep it genuinely secret and take reasonable steps to do so, but it offers no protection at all if someone independently discovers or reverse-engineers the same thing.
The framework worth applying to your own invention is not "which one is better" but "which one fits how this specific thing can be discovered."
- If a competitor could learn how your product works by buying it, taking it apart, and studying it, a trade secret offers weak protection, because reverse engineering defeats it. A patent may be worth examining more seriously here.
- If your advantage is a process, formula, or internal method that never leaves your walls, a trade secret may offer stronger, longer protection than a patent would, without the cost or public disclosure that patenting requires.
- If you are building software where the specific implementation changes constantly but the underlying method is stable, this is genuinely one of the harder cases, and it is worth a direct conversation with an attorney about what aspects, if any, are worth pursuing formally.
Many companies use both, applying for patents on the parts of the invention that are visible or discoverable once the product ships, while keeping manufacturing details, internal tooling, or data pipelines as trade secrets. This layered approach is often more realistic for an early-stage company than betting everything on one path.
Budget as a strategic constraint, not an afterthought
Patent prosecution costs money at every stage: provisional filing, nonprovisional filing, attorney fees for responding to office actions, and eventually maintenance fees if a patent issues. A pre-seed company with limited runway cannot file broadly across every possible claim and every country. This is a real constraint, and treating it as a strategic input rather than a source of anxiety tends to produce better decisions.
A useful exercise is to rank the two or three inventions or mechanisms in your product that would hurt the most if a competitor copied them tomorrow. Those are candidates for provisional filings first. Everything else can wait, be handled as a trade secret, or be revisited once you have raised the capital to file more broadly.
Building the story you tell in diligence
When an investor's counsel eventually reviews your IP position, they are looking for coherence more than volume. A single well-timed provisional filing, filed before your first substantial public disclosure, paired with a clear rationale for what you chose to keep as a trade secret, reads as a company that made deliberate choices. A messy history of disclosures before filings, or filings that do not match what the product actually became, reads as a company that treated IP as an afterthought.
The goal is not to appear impressive. It is to appear consistent: your public statements, your filings, and your actual product roadmap should tell the same story, filed in the right order.
Where to go from here
Before your next investor conversation, it is worth sitting down with a simple timeline. List every public disclosure you have already made, including pitch decks sent without an NDA, demos, and press coverage, with dates. Then list every filing, if any, with dates. Look at the gaps.
If disclosures came before filings, that is not necessarily a closed door, but it is a fact worth bringing to a patent attorney directly rather than discovering later during diligence. If filings came first, you have a foundation to build the layered story described above: what is patented or pending, what is intentionally kept as a trade secret, and why each choice fits how your invention can actually be discovered or copied.
Either way, the real question is not "is my idea patentable." It is whether you can describe, clearly and in order, the choices you made about protecting it. That clarity, more than any single filing, is what an early moat is actually built from.
